Bio-UV Group SA(FR:ALTUV)
€0.840.00 (0.00%)
FR:ALTUV
Bio-UV Group SA financials statements
€0.84
At close:0.00 (0.00%)
Want to see FR:ALTUV full AI Analyst Report?
Bio-UV Group SA (ALTUV) Ratios
0 Followers
Bio-UV Group SA Ratios
FR:ALTUV's free cash flow for Q2 2026 was €-200.00K. For the 2026 fiscal year, FR:ALTUV's free cash flow was decreased by €-700.00K and operating cash flow was €500.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.06 | 1.64 | 1.33 | 1.65 | 1.85 |
| Quick Ratio | 1.25 | 0.84 | 0.62 | 0.61 | 1.07 |
| Cash Ratio | 0.67 | 0.27 | 0.13 | 0.11 | 0.54 |
| Solvency Ratio | 0.13 | 0.10 | 0.09 | 0.12 | 0.06 |
| Operating Cash Flow Ratio | 0.36 | 0.48 | 0.30 | 0.14 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 0.91 | 1.36 | 0.63 | 11.48 | 0.75 |
| Net Current Asset Value | € -2.10M | € -9.72M | € -11.49M | € -10.72M | € -15.41M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.36 | 0.40 | 0.39 | 0.38 |
| Debt-to-Equity Ratio | 0.50 | 0.73 | 0.88 | 0.90 | 1.01 |
| Debt-to-Capital Ratio | 0.33 | 0.42 | 0.47 | 0.47 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.33 | 0.31 | 0.46 | 0.45 |
| Financial Leverage Ratio | 1.71 | 2.02 | 2.22 | 2.30 | 2.66 |
| Debt Service Coverage Ratio | 0.26 | 0.70 | 0.42 | 6.36 | 0.71 |
| Interest Coverage Ratio | 1.56 | 2.75 | 2.26 | 6.10 | 2.74 |
| Debt to Market Cap | 0.88 | 0.92 | 1.00 | 0.58 | 0.54 |
| Interest Debt Per Share | 1.48 | 2.39 | 2.88 | 2.94 | 3.06 |
| Net Debt to EBITDA | 7.22 | 4.82 | 5.77 | 4.26 | 6.13 |
| Profitability Margins | |||||
| Gross Profit Margin | 5.56% | 60.87% | 59.29% | 9.18% | 5.50% |
| EBIT Margin | -3.34% | 2.19% | 2.39% | 7.16% | 2.98% |
| EBITDA Margin | 4.46% | 10.55% | 10.27% | 12.43% | 10.00% |
| Operating Profit Margin | 3.29% | 5.39% | 5.33% | 8.06% | 2.98% |
| Pretax Profit Margin | 2.51% | 0.23% | 0.04% | 5.84% | 1.89% |
| Net Profit Margin | 2.33% | 0.08% | 0.29% | 4.71% | 2.06% |
| Continuous Operations Profit Margin | 2.33% | 0.08% | 0.29% | 4.71% | 2.06% |
| Net Income Per EBT | 92.75% | 33.98% | 803.83% | 80.73% | 109.19% |
| EBT Per EBIT | 76.28% | 4.33% | 0.68% | 72.49% | 63.28% |
| Return on Assets (ROA) | 1.21% | 0.05% | 0.17% | 3.26% | 0.85% |
| Return on Equity (ROE) | 2.07% | 0.10% | 0.39% | 7.50% | 2.26% |
| Return on Capital Employed (ROCE) | 2.10% | 4.13% | 4.55% | 7.47% | 1.61% |
| Return on Invested Capital (ROIC) | 1.79% | 1.27% | 3.77% | 6.00% | 1.50% |
| Return on Tangible Assets | 2.51% | 0.11% | 0.38% | 74.86% | 4.71% |
| Earnings Yield | 3.99% | 0.14% | 0.50% | 5.11% | 1.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.76 | 11.41 | 8.26 | 9.85 | 6.40 |
| Payables Turnover | 10.00 | 3.68 | 3.03 | 6.36 | 5.85 |
| Inventory Turnover | 3.26 | 1.35 | 1.19 | 2.37 | 2.14 |
| Fixed Asset Turnover | 6.78 | 7.45 | 8.27 | 16.64 | 11.62 |
| Asset Turnover | 0.52 | 0.60 | 0.60 | 0.69 | 0.41 |
| Working Capital Turnover Ratio | 3.13 | 4.94 | 4.53 | 3.63 | 1.77 |
| Cash Conversion Cycle | 129.57 | 203.90 | 230.69 | 133.66 | 165.41 |
| Days of Sales Outstanding | 54.03 | 32.00 | 44.18 | 37.05 | 56.99 |
| Days of Inventory Outstanding | 112.02 | 271.02 | 306.89 | 154.04 | 170.83 |
| Days of Payables Outstanding | 36.49 | 99.11 | 120.38 | 57.43 | 62.41 |
| Operating Cycle | 166.06 | 303.01 | 351.07 | 191.09 | 227.82 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.33 | 0.67 | 0.61 | 0.27 | 0.32 |
| Free Cash Flow Per Share | 0.21 | 0.48 | 0.42 | 0.05 | 0.06 |
| Dividend Paid and CapEx Coverage Ratio | 2.83 | 3.63 | 2.43 | 0.99 | 1.21 |
| Capital Expenditure Coverage Ratio | 2.83 | 3.63 | 3.18 | 1.21 | 1.21 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.29 | 0.22 | 0.09 | 0.11 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.17 | 0.14 | 0.05 | 0.10 |
| Free Cash Flow Yield | 14.32% | 21.94% | 17.25% | 1.01% | 1.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.13 | 726.68 | 198.49 | 19.57 | 77.20 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.58 | 0.57 | 0.92 | 1.59 |
| Price-to-Book (P/B) Ratio | 0.52 | 0.70 | 0.77 | 1.47 | 1.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.99 | 4.56 | 5.80 | 99.42 | 93.09 |
| Price-to-Operating Cash Flow Ratio | 4.53 | 3.30 | 3.97 | 17.55 | 16.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -9.61 | -2.09 | 0.08 | -175.50 |
| Enterprise Value Multiple | 20.32 | 10.27 | 11.36 | 11.68 | 22.03 |
| Enterprise Value | 32.51M | 42.91M | 50.33M | 74.50M | 73.74M |
| EV to EBITDA | 20.32 | 10.27 | 11.36 | 11.68 | 22.03 |
| EV to Sales | 0.91 | 1.08 | 1.17 | 1.45 | 2.20 |
| EV to Free Cash Flow | 10.84 | 8.58 | 11.77 | 156.50 | 128.99 |
| EV to Operating Cash Flow | 7.02 | 6.22 | 8.07 | 27.63 | 22.36 |
| Tangible Book Value Per Share | 0.33 | -0.40 | -0.59 | -3.80 | -3.52 |
| Shareholders’ Equity Per Share | 2.86 | 3.16 | 3.17 | 3.18 | 3.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | 0.66 | -7.04 | 0.19 | -0.09 |
| Revenue Per Share | 2.54 | 3.82 | 4.25 | 5.06 | 3.29 |
| Net Income Per Share | 0.06 | 0.00 | 0.01 | 0.24 | 0.07 |
| Tax Burden | 0.93 | 0.34 | 8.04 | 0.81 | 1.09 |
| Interest Burden | -0.75 | 0.11 | 0.02 | 0.82 | 0.63 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.07 | 0.04 | 0.00 |
| SG&A to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 5.54 | 220.02 | 49.96 | 1.12 | 4.78 |
Currency in EUR

